Intravenous Infusions (XGHA:IIL) Total Debt per Share: GHS0.00 (As of . 20)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XGHA:IIL Intravenous Infusions Ltd XGHA:IIL
3 GF Score
Price GHS0.46
View Full Analysis

What is Intravenous Infusions Total Debt per Share?

Intravenous Infusions XGHA:IIL +6.98% 3 Total Debt per Share is GHS0.00 as of . 20. GuruFocus rates XGHA:IIL with a GF Score™ of 3/100.

GHS0.00 (As of . 20)

Total Debt per Share is calculated as total debt divided by Shares Outstanding (EOP). Total debt is calculated as Long-Term Debt & Capital Lease Obligation plus Short-Term Debt & Capital Lease Obligation. Intravenous Infusions's Total Debt Per Share for the quarter that ended in . 20 was GHS0.00.

Intravenous Infusions Total Debt per Share Historical Data

* Premium members only.

The historical data trend for Intravenous Infusions's Total Debt per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Intravenous Infusions Total Debt per Share Chart

Intravenous Infusions Annual Data
Trend
Total Debt per Share

Intravenous Infusions Semi-Annual Data
Total Debt per Share
XGHA:IIL
3GF Score
Intravenous Infusions Ltd XGHA:IIL
Total Debt per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Intravenous Infusions Total Debt per Share Calculation

Intravenous Infusions's Total Debt Per Share for the fiscal year that ended in . 20 is calculated as:

Total Debt Per Share=(Long-Term Debt & Capital Lease Obligation+Short-Term Debt & Capital Lease Obligation)/Shares Outstanding (EOP)
=(0.00+0.00)/0.00
=N/A

Intravenous Infusions's Total Debt Per Share for the quarter that ended in . 20 is calculated as:

Total Debt Per Share=(Long-Term Debt & Capital Lease Obligation+Short-Term Debt & Capital Lease Obligation)/Shares Outstanding (EOP)
=(0.00+0.00)/0.00
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Debt per Share →
What does a Total Debt per Share of GHS0.00 mean?
Intravenous Infusions (XGHA:IIL) has a Total Debt per Share of GHS0.00 as of . 20. Total debt per share equals the per-share value of a company's long-term and short-term debt. View historical data on Intravenous Infusions and its competitors.
Is Intravenous Infusions' Total Debt per Share too high?
Intravenous Infusions' current Total Debt per Share is GHS0.00. Overall, Intravenous Infusions has a GF Score™ of 3/100, reflecting its overall financial health beyond just this single metric.
How does Intravenous Infusions' Total Debt per Share compare to PTLF and PCYN?
Intravenous Infusions' Total Debt per Share of GHS0.00 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Debt per Share for a Drug Manufacturers company?
A good Total Debt per Share depends on the Drug Manufacturers industry context. However, Total Debt per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Debt per Share mean?
A high Total Debt per Share can signal that a stock is expensive relative to its fundamentals. Total debt per share equals the per-share value of a company's long-term and short-term debt. View historical data on Intravenous Infusions and its competitors. Intravenous Infusions's current Total Debt per Share is GHS0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Intravenous Infusions stock overvalued right now?
Intravenous Infusions (XGHA:IIL) has a current Total Debt per Share of GHS0.00. The current Total Debt per Share is GHS0.00. Intravenous Infusions' overall GF Score™ is 3/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Debt per Share calculated?
Total Debt per Share is calculated from a company's financial statements. For Intravenous Infusions (XGHA:IIL), the current Total Debt per Share is GHS0.00 as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Intravenous Infusions Business Description

Address Plot 4/7 Blk L, P.O Box KF 63, Effiduase-Koforidua, GHA
Intravenous Infusions Ltd engages in the production of intravenous infusion and small-volume injectables for therapeutic purposes. The product categories are IV fluids, giving sets, and small-volume injectables. The company earns a majority of its revenue from IV fluids. Some of the IV fluids are sodium chloride solutions, dextrose solutions, dextrose saline solutions, and dextran solutions. Small-volume injectables include pethidine injection, magnesium sulphate injection, and quinine injection. Giving sets include plain giving sets, and blood giving sets.
3GF Score

Get the complete analysis for XGHA:IIL

Total Debt per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

GHS0.46
Price